title: Brain natriuretic peptide as a marker of cardiac toxicity in patients with multiple sclerosis treated with mitoxantrone.
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Bertora
authors.forename: Daniela
authors.initials: D
authors.lastname: Torzillo
authors.forename: Gabriella
authors.initials: G
authors.lastname: Baldi
authors.forename: Tarcisio
authors.initials: T
authors.lastname: Vago
authors.forename: Claudio
authors.initials: C
authors.lastname: Mariani
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D009202:Cardiomyopathies / Q000097:blood* / Q000139:chemically induced / Q000175:diagnosis*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000009:adverse effects*; D008991:Monitoring, Physiologic; D009103:Multiple Sclerosis / Q000188:drug therapy*; D020097:Natriuretic Peptide, Brain / Q000032:analysis / Q000097:blood*; D011237:Predictive Value of Tests
chemical_list: D000970:Antineoplastic Agents; D015415:Biomarkers; D020097:Natriuretic Peptide, Brain; D008942:Mitoxantrone